Alignment Healthcare Holdings Stock Earnings Reports

Key points for investors: Alignment reported a strong Q1 2026 with membership of 284,800 (up ~31% YoY) supporting revenue of $1.2B (+33% YoY). Adjusted gross profit was $146M with an adjusted MBR of 88.2% (20 bps improvement YoY). Adjusted SG&A improved as a percent of revenue to 8.7% and adjusted EBITDA was $38M (88% growth YoY), beating guidance and implying a 3.1% margin. Management attributed performance to strong sales, retention, and clinical execution, while calling out and quickly correcting a January observation/authorization workflow issue that temporarily increased inpatient admits. They highlighted operational improvements (claims auto-adjudication improved from <15% to >60% YTD), ongoing automation and AI investments (claims, contract management, risk stratification), and disciplined hiring to scale. Liquidity remains strong with $726M cash and a funded leverage ratio of 2.6x TTM EBITDA. Guidance was raised: full-year 2026 membership now expected ~294k–299k, revenue $5.16B–$5.21B, adjusted gross profit $620M–$650M, and adjusted EBITDA $138M–$163M. CapEx guidance centers on ~ $40M of primarily software development spend in 2026 (may tick up moderately). Management reiterated strategic focus on growing into higher-acuity populations, pursuing scalable provider engagement outside California, potential future in-sourcing of certain supplemental benefit offerings, and continued participation in targeted pilots (e.g., limited GLP-1 bridge programs) while preparing bids for 2027.